We are extracting outer membrane proteins from gram-negative bacteria as vaccine candidate antigens. However, we did not know how to quality control of bacterial outer membrane proteins. As we all know, outer membrane protein complex (OMPC) of Neisseria meningitidis group B had been used as carrier protein of carbohydrate conjugate vaccine, such as PedvaxHIB. In addition, there are other bacterial outer membrane proteins that have entered clinical trials as vaccine antigens. In those cases, how to quality control of bacterial outer membrane proteins? Thank you very much.

More Haibo Li's questions See All
Similar questions and discussions